Infant Death Spike in Mississippi Sparks Drug Policy Debate on Ivermectin
A recent surge in infant deaths across Mississippi has intensified debates around healthcare access, affordability, and policy reforms....
Why Is Ivermectin Making a Comeback in the U.S.?
In recent years, Ivermectin comeback story 2025 has undergone a rollercoaster journey—from widespread use to controversy and now an unexpected revival....
CHMP Approves Ivermectin/Albendazole Combo for Parasitic Infections
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recently given a landmark CHMP ivermectin albendazole approval...
